Delivery Order 36C25621D0088-36C25624F0005
Award Date 10/1/23
Potential Completion Date 9/30/24
Potential Value Not listed
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Shreveport, LA 71105, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 16 awarded a $0.00 firm fixed price delivery order to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy. The delivery order was issued on October 1, 2022 against EO14042 HAZARDOUS STERILE COMPOUND to provide such products and services through September 30, 2023. Optum Pharmacy 801, Inc. is a subsidiary of UnitedHealth Group Incorporated, doing business as UnitedHealth...
- <p>The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 (VA - VHA) awarded a $900,000 firm fixed price blanket purchase agreement call contract to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, a subsidiary of UnitedHealth Group Incorporated, doing business as UnitedHealth Group. The contract is for chemotherapy compounding services to be performed in Phoenix, Arizona between November 2021 and November 2026.</p>
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 awarded a $76,500 firm fixed price delivery order for pharmacy compounding services to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy. Optum Pharmacy 801 is a subsidiary of UnitedHealth Group Incorporated, a large health services company. Under this contract, Avella Specialty Pharmacy will provide compounded pharmaceutical preparations to support health care programs...
- This federal contract award is for the delivery of hazardous sterile compound pharmaceutical services, specifically for the Department of Veterans Affairs (VA) healthcare system. The contract, valued at $100,000.00, was awarded to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, a subsidiary of UnitedHealth Group Incorporated. The contract is a delivery order under a Firm Fixed Price (FFP) arrangement, with a period of performance through September 30, 2025. The contract...
- This federal contract award, valued at $230,297.50, was issued by the Department of Veterans Affairs Veterans Health Administration (VA-VHA) to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, a subsidiary of UnitedHealth Group Incorporated. The contract is for the delivery of sterile compound supply services to support VA oncology and infusion treatment programs nationwide. As the prime contractor, Avella Specialty Pharmacy will compound customized chemotherapy and other...
- The U.S. Department of Veterans Affairs Veterans Health Administration (VA-VHA) awarded a $216,982.32 firm fixed-price definitive contract for compounding services to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, a subsidiary of UnitedHealth Group Incorporated. The contract, which has no set-aside designation, was awarded on December 26, 2019 with a completion date of December 25, 2020. As the prime contractor, Avella Specialty Pharmacy will provide specialized...
- This federal contract award was issued by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 21 (VISN 21) to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, a subsidiary of UnitedHealth Group Incorporated. The $441,256.72 firm fixed-price delivery order is for the provision of hazardous pharmaceutical compounds to support VA oncology and infusion treatment programs in Las Vegas, Nevada. The contract has no set-aside designation and is not...
- The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a firm-fixed-price purchase order contract to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, a subsidiary of UnitedHealth Group Incorporated. The $1,875,405.34 contract is for the provision of compounded chemotherapy drugs to support VA oncology and infusion treatment programs at the VA Long Beach Healthcare System in California. The contract period of performance is April 2, 2019 to...
- This is a federal contract award by the U.S. Department of Veterans Affairs (VA) to Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated. The $497,705.58 contract is for "CONTINGENCY HAZARDOUS PHARMACEUTICAL COMPOUNDING - RENO" and has an ultimate completion date of September 30, 2024. The contract is a Delivery Order under an Indefinite Delivery Vehicle (IDV) and has a Firm Fixed Price pricing type. Optum Pharmacy 801, Inc., operating as Avella Specialty Pharmacy,...
- The Department of Veterans Affairs (VA) has awarded a Delivery Order contract to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, a subsidiary of UnitedHealth Group Incorporated. The $40,000.00 Firm Fixed Price contract is for pharmacy compounding services to support VA oncology and infusion treatment programs nationwide. Avella, which is a 503A certified pharmacy, will leverage its expertise in aseptic techniques for hazardous drug preparation to deliver customized...
- 36C25621D0088Indefinite Delivery Contract
- 36C25621D0088-36C25624F0005Delivery Order
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 16 (VA - VHA) awarded a $486,735.00 delivery order contract to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, a subsidiary of UnitedHealth Group Incorporated, doing business as UnitedHealth Group. The contract is for EO14042 Hazardous Sterile Compound - Exercise Option Year Two and will be performed in Shreveport, Louisiana, running from October 1, 2023 through September 30, 2024. The pricing for the hazardous sterile compounding services is fixed.
Generated 11/28/23, 7:11 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Funding Only Action | ($150k) | 12/31/24 | |
| P00001 | Funding Only Action | ($337k) | 1/20/24 | |
| Not listed | Not listed | $486.7k | 10/1/23 |